REQUEST A DEMO
Total
USD $0.00
Search more companies

Helios Pharma S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Helios Pharma S.R.O. Profile Updated: August 26, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Helios Pharma S.R.O. is an enterprise located in Czech Republic, with the main office in Trebic. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on September 06, 2005. Helios Pharma S.R.O. currently employs 20 - 24 (2025) people. The company’s latest financial report indicates a net sales revenue increase of 10.33% in 2025. During that time, Helios Pharma S.R.O.’s total assets grew by 29.11%. In 2025, Helios Pharma S.R.O.’s net profit margin decreased by 0.76%.

Headquarters
Vltavinska 1289/10
Trebic; Kraj Vysocina; Postal Code: 67401

Contact Details: Purchase the Helios Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Helios Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Helios Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Helios Pharma S.R.O. report to view the information.
Incorporation Date:
September 06, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Helios Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
10.33%
Total Operating Revenue
10.33%
Operating Profit
-2.29%
EBITDA
-2.45%
Net Profit/Loss for the Period
-0.96%
Total Assets
29.11%
Total Equity
33.74%
Operating Profit Margin
-1.15%
Net Profit Margin
-0.76%
Return on Equity (ROE)
-8.84%
Quick Ratio
0.37%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?